Bordeaux, France

Elisabeth Garanger

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Elisabeth Garanger: Innovator in Multifunctional Probes

Introduction

Elisabeth Garanger is a prominent inventor based in Bordeaux, France. She has made significant contributions to the field of biotechnology, particularly in the development of multifunctional probes. With a total of 2 patents, her work is paving the way for advancements in various applications.

Latest Patents

Elisabeth's latest patents focus on methods and reagents for preparing multifunctional probes. These multifunctional probes consist of a substrate, such as a nanoparticle, polymer, antibody, protein, low molecular weight compound, or drug, combined with a multifunctional single-attachment-point (MSAP) reagent. The MSAP reagents include three essential components: a peptide scaffold, a single chemically reactive group for interaction with a complementary reactive group on the substrate, and multiple functional groups on the peptide scaffold. For ease of synthesis and reproducibility in clinical trials, it is preferred to limit the residues in the peptide to 20 or less. The synthesis of these multifunctional probes is achieved in a single step using peptide scaffold-based MSAP reagents.

Career Highlights

Elisabeth Garanger is currently associated with The General Hospital Corporation, where she continues to innovate and develop her research. Her work has garnered attention for its potential applications in medical and scientific fields.

Collaborations

Elisabeth collaborates with Lee Josephson, enhancing her research efforts and contributing to the advancement of multifunctional probes.

Conclusion

Elisabeth Garanger's innovative work in the field of multifunctional probes showcases her dedication to advancing biotechnology. Her patents and collaborations reflect her significant impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…